The ligand–receptor pairs involving migration inhibitory factor (MIF) and CXCR7/CD44 may contribute to differing joint symptoms between sJIA and non-sJIA patients. This evidence concerns the gene ACKR3 and systemic-onset juvenile idiopathic arthritis.